Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension.

Background: The 6-min walk test, commonly used to assess exercise capacity and response to therapy in pulmonary arterial hypertension (PAH), has many well-described limitations. Sedentary time is associated with adverse cardiovascular outcomes and reduced quality of life, and measuring sedentary tim...

Descripción completa

Detalles Bibliográficos
Publicado en:CHEST Vol. 142; no. 6; pp. 1391 - 1399
Autores principales: Pugh, Meredith E, Buchowski, Maciej S, Robbins, Ivan M, Newman, John H, Hemnes, Anna R
Formato: research Journal Article
Publicado: American College of Chest Physicians Dec2012
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107984601&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107984601
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00123692
        1G4
      jtl: CHEST
      issn: 00123692
      maglogo: N
    pubinfo:
      dt: Dec2012
      vid: 142
      iid: 6
      pid: 2556
      pub: American College of Chest Physicians
      place: Glenview, Illinois
    artinfo:
      ui:
        107984601
        NLM22576635
        2012013732
        10.1378/chest.12-0150
        NLM22576635
        PMC3515022
        107984601
      ppf: 1391
      ppct: 8
      formats:
      tig:
        atl: Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension.
      aug:
        au:
          Pugh, Meredith E
          Buchowski, Maciej S
          Robbins, Ivan M
          Newman, John H
          Hemnes, Anna R
        affil: Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. meredith.e.pugh@vanderbilt.edu
      sug:
        subj:
          Exercise Tolerance
          Hypertension, Pulmonary
          Motor Activity
          Activities of Daily Living
          Adult
          Aged
          Case Control Studies
          Female
          Human
          Sedentary Behavior
          Male
          Middle Age
          Pilot Studies
          Walking Physiology
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Background: The 6-min walk test, commonly used to assess exercise capacity and response to therapy in pulmonary arterial hypertension (PAH), has many well-described limitations. Sedentary time is associated with adverse cardiovascular outcomes and reduced quality of life, and measuring sedentary time and physical activity using accelerometry is another potential way to quantify exercise capacity in PAH. Whether sedentary time is different in patients with PAH vs control subjects is unknown.Methods: Physical activity was measured in 20 patients with PAH and 30 matched healthy control subjects using accelerometry for 7 consecutive days. Patients with PAH completed standard 6-min walk testing, and baseline demographics were recorded for all study participants. Total daily activity counts, sedentary time, and proportion of time at various activity levels were compared between groups.Results: Sedentary time was significantly higher in patients with PAH (mean, 92.1% daily activity; 95% CI, 89.5-94.8%) than in control subjects (mean, 79.9% daily activity; 95% CI, 76.4%-83.5%; P < .001), and all levels of physical activity were reduced in the PAH group compared with the control group ( P < .01 for all). Daily moderate to vigorous physical activity was reduced in the PAH group (7.5 min; 95% CI; 0.8-15.6 min) compared with the control group (mean, 64.7 min; 95% CI, 51.1-78.2 min; P < .001). Activity counts correlated with 6-min walk distance in the PAH group (Spearman rank correlation 5 0.72, P < .001).Conclusions: Sedentary time is increased in patients with PAH and may lead to increased risk for metabolic and cardiovascular morbidity. Quantitation of daily activity and sedentary time using accelerometry may be a novel end point for PAH management and clinical trials.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N